3.9000.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Overview
RECBIO-B (2179)
Jiangsu Recbio Technology Co., Ltd., a vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic...
- Open
- 3.900
- High
- 3.900
- Low
- 3.900
- Prev. Close
- 3.900
- Volume
- 500
- Turnover
- 1.95K
- Avg Price
- 3.900
- Bid/Ask Ratio
- -100.00%
- Amplitude
- 0.00%
- 52wk High
- 6.700
- Volume Ratio
- 0.35
- Turnover Ratio
- 0.00%
- 52wk Low
- 1.000
- HK Mkt Cap
- 1.79B
- Market CapHKD
- 2.44B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.886
- EPSDynamic
- -0.779
- EPSStatic
- --
- BVPS
- 0.92
- P/B
- 4.26
- HK Shares
- 458.09M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 626.08M
- Min lot size
- 500
- Currency
- HKD
RECBIO-B Analyst Rating
View moreForecast & Rating
Apr 17, 2025Price forecast
HK$12.99233.01%
Forecast & Rating-
News
Quartr · CBIO: CR-001 aims to become a next-generation IO backbone, with phase III starts targeted for early 2028
Market Movers · Recbio falls 3%
PUBT · Jiangsu Recbio Expects REC603 HPV Vaccine Launch in 2029-2030 as Clinical Data Collection Takes Longer
Tip Ranks · Jiangsu Recbio Announces Board-Level Resignation and New Authorised Representative
PUBT · Jiangsu Recbio files board, committee member roster for disclosure duties
Tip Ranks · Jiangsu Recbio Clarifies Board Composition and Committee Leadership
